Skip to main content
SpringerLink
Log in

Guidelines for Anticoagulation of Atrial Fibrillation: Is It Time for an Update?

  • Chapter
Cardiac Arrhythmias 2005

  • 659 Accesses

Conclusions

Several areas regarding use of oral anticoagulation have been identified which are in need of updating or reconsideration. Recommendations are always best when data-driven. For some of these areas, the data are lacking, weak, or controversial. For others, the data seem clear. Because these several areas are important, we hope they will gain the attention they deserve from the ACC/AHA/ESC and ACCP guideline committees.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Go AS, Hylek EM, Phillips KA et al for the AnTicoagulation and Risk factors In Atrial Fibrillation (ATRIA) Study (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. JAMA 285:2370–2375

    Article  PubMed  CAS  Google Scholar 

  2. Waldo AL (2003) Stroke prevention in atrial fibrillation. JAMA 209:1093–1095

    Article  Google Scholar 

  3. Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147:1561–1564

    Article  PubMed  CAS  Google Scholar 

  4. Feinberg WM, Blackshear JL, Laupacis A et al (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473

    Article  PubMed  CAS  Google Scholar 

  5. Petersen P, Madsen EB, Brun B et al (1987) Silent cerebral infarction in chronic atrial fibrillation. Stroke 18:1098–1100 (abs)

    PubMed  CAS  Google Scholar 

  6. Guidotti M, Tadeo G, Zanasi S et al (1990) Silent cerebral ischemia in patients with chronic atrial fibrillation: a case-control study. Irish J Med Sci 159:96–97

    Article  PubMed  CAS  Google Scholar 

  7. Feinberg WM, Seeger JF, Carmody RF et al (1990) Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med 150:2340–2344 (abs)

    Article  PubMed  CAS  Google Scholar 

  8. Ezekowitz MD, James KE, Nazarian SM et al for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (1995) Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 92:2178–2182

    PubMed  CAS  Google Scholar 

  9. Singer DE, Albers GW, Dalen JE et al (2004) Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:429S–456S

    Article  PubMed  CAS  Google Scholar 

  10. Fuster V, Ryden LE, Asinger RW et al (2002) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:1231–1266

    Article  Google Scholar 

  11. Ezekowitz MD, Levine JA (1999) Preventing stroke in patients with atrial fibrillation. JAMA 281:1830–1835

    Article  PubMed  CAS  Google Scholar 

  12. van Walraven C, Hart RG, Singer DE et al (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288:2441–2448

    Article  PubMed  Google Scholar 

  13. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492–501

    PubMed  CAS  Google Scholar 

  14. Anonymous (1993) A differential effect of aspirin in prevention of stroke on atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. J Stroke Cerebrovasc Dis 3:181–188

    Article  Google Scholar 

  15. Hylek EM, Go AS, Chang Y et al (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026

    Article  PubMed  CAS  Google Scholar 

  16. Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897–902

    PubMed  CAS  Google Scholar 

  17. Fang MC, Chang Y, Hylek EM et al (2004) Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141:745–752

    PubMed  Google Scholar 

  18. Wyse DG, Waldo AL, DiMarco JP et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 34:1825–1833

    Google Scholar 

  19. Bhandari AK, Anderson JL, Gilbert M et al; Flecainide Supraventricular Tachycardia Study Group (1992) Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J 124:381–386

    Article  PubMed  CAS  Google Scholar 

  20. Page RL, Wilkerson WE, Clark WK et al (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89:224–227

    PubMed  CAS  Google Scholar 

  21. Savelieva I, Camm AJ (2000) Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Intervent Cardiac Electrophysiol 4:369–382

    Article  CAS  Google Scholar 

  22. Israel C, Ehrlich JR, Gronefeld G et al (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optional patient care. J Am Coll Cardiol 43:47–52

    Article  PubMed  Google Scholar 

  23. Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1105

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Case Western Reserve University/University Hospitals of Cleveland, Cleveland, OH, USA

    A. L. Waldo

Authors
  1. A. L. Waldo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Waldo, A.L. (2006). Guidelines for Anticoagulation of Atrial Fibrillation: Is It Time for an Update?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_23

Download citation

  • DOI: https://doi.org/10.1007/88-470-0371-7_23

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0370-5

  • Online ISBN: 978-88-470-0371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation